Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MACROGENICS INC Director's Dealing 2014

May 30, 2014

34129_dirs_2014-05-30_b5136df7-7f6b-4243-8bc4-8c1298ae0fff.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2014-05-29

Reporting Person: Stein Kathryn E (Senior VP, Prd Dev & Reg Aff)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-05-29 Common Stock M 10946 $0.71 Acquired 54151 Direct
2014-05-29 Common Stock S 10946 $19.75 Disposed 43205 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-05-29 Stock Option (right to buy) $0.71 M 10653 Disposed 2015-12-15 Common Stock (10653) Direct
2014-05-29 Stock Option (right to buy) $0.71 M 293 Disposed 2015-03-24 Common Stock (293) Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.50 to $19.91, inclusive. The reporting person undertakes to provide to MacroGenics, Inc., any security holder of MacroGenics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.

F2: The shares underlying the option became fully exercisable on December 15, 2009.

F3: The shares underlying the option became fully exercisable on March 24, 2009.